Prion-like Mechanism in Amyotrophic Lateral Sclerosis: are Protein Aggregates the Key?

Experimental Neurobiology
Shynrye Lee, Hyung-Jun Kim

Abstract

ALS is a fatal adult-onset motor neuron disease. Motor neurons in the cortex, brain stem and spinal cord gradually degenerate in ALS patients, and most ALS patients die within 3~5 years of disease onset due to respiratory failure. The major pathological hallmark of ALS is abnormal accumulation of protein inclusions containing TDP-43, FUS or SOD1 protein. Moreover, the focality of clinical onset and regional spreading of neurodegeneration are typical features of ALS. These clinical data indicate that neurodegeneration in ALS is an orderly propagating process, which seems to share the signature of a seeded self-propagation with pathogenic prion proteins. In vitro and cell line experimental evidence suggests that SOD1, TDP-43 and FUS form insoluble fibrillar aggregates. Notably, these protein fibrillar aggregates can act as seeds to trigger the aggregation of native counterparts. Collectively, a self-propagation mechanism similar to prion replication and spreading may underlie the pathology of ALS. In this review, we will briefly summarize recent evidence to support the prion-like properties of major ALS-associated proteins and discuss the possible therapeutic strategies for ALS based on a prion-like mechanism.

References

Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·S KatoE Ohama
Aug 16, 2006·Neuro-degenerative Diseases·Ashutosh Tiwari, Lawrence J Hayward
Feb 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Christine Vande VeldeDon W Cleveland
Oct 16, 2010·Prion·Kevin C Gough, Ben C Maddison
Jan 14, 2011·Journal of Neurochemistry·Per ZetterströmStefan L Marklund
Jan 19, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Terry D Heiman-PattersonGregory Cox
Feb 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Christian MünchAnne Bertolotti
Aug 13, 2011·Nature Biotechnology·Amanda M Haidet-PhillipsBrian K Kaspar
Aug 19, 2011·Prion·Aaron D Gitler, James Shorter
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Leslie I GradNeil R Cashman
Nov 1, 2011·Cell·Magdalini Polymenidou, Don W Cleveland
Dec 1, 2011·Nature Reviews. Neuroscience·Edward B LeeJohn Q Trojanowski
May 25, 2012·Nature·Julie A MorenoGiovanna R Mallucci
Sep 4, 2012·International Journal of Molecular Sciences·Alessandro CorsaroTullio Florio
May 16, 2013·Acta Neuropathologica·Anna M BlokhuisR Jeroen Pasterkamp
Jul 9, 2013·Cell Reports·Takashi NonakaMasato Hasegawa
Aug 1, 2013·Human Molecular Genetics·Jonathan Janssens, Christine Van Broeckhoven
Nov 15, 2013·Clinical & Developmental Immunology·Kristen MarciniukScott Napper
Nov 28, 2013·The Journal of Biological Chemistry·Takao NomuraYoshiaki Furukawa
Dec 11, 2013·International Journal of Cell Biology·Soledad MatusClaudio Hetz
Dec 27, 2013·Nature Neuroscience·Alan E RentonBryan J Traynor
Jan 1, 2014·Frontiers in Cellular Neuroscience·Melissa S Rotunno, Daryl A Bosco
Jun 15, 2014·Trends in Neurosciences·Steve VucicMatthew C Kiernan
Jun 29, 2014·Disease Models & Mechanisms·Shunmoogum A PattenPierre Drapeau

❮ Previous
Next ❯

Citations

Jan 19, 2016·Brain Pathology·Fabiola PuentesSandra Amor
Jan 19, 2016·Brain Pathology·Simona RossiMaria Teresa Carrì
Jul 29, 2015·Acta Neuropathologica Communications·Manaal FatimaJillian J Kril
Apr 1, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Gianluigi ForloniClaudia Balducci
Apr 27, 2016·Nucleus·Ke ZhangThomas E Lloyd
May 6, 2016·International Journal of Molecular Sciences·Yann GambinEmma Sierecki
Oct 25, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Kunjumon I Vadakkan
Mar 27, 2016·Journal of Neurochemistry·Antonia Ratti, Emanuele Buratti
Jan 20, 2017·Scientific Reports·Francescaelena De RoseAnna Liscia
Oct 14, 2017·Journal of Neural Transmission·Marie-Victoire Guillot-Sestier, Terrence Town
Oct 6, 2017·Nature Reviews. Disease Primers·Orla HardimanLeonard H van den Berg
Dec 19, 2015·Physiological Reviews·Xin Gen LeiElias S J Arnér
Dec 6, 2019·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Takahiro TakedaKimihito Arai
Sep 19, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Surbhi SharmaMartin R Schiller
Apr 15, 2018·Journal of Cell Science·Edward ChuangJames Shorter
Jul 9, 2020·Medicinal Research Reviews·Maria Zakharova
Feb 24, 2017·Molecular Neurobiology·Laura UrreaJosé Antonio Del Río
Nov 8, 2018·Scientific Reports·Chen BenklerLee L Rubin
Jul 25, 2019·Veterinary Pathology·Alyona V MichaelJodi D Smith
Dec 24, 2019·Frontiers in Neuroscience·Rita MejziniP Anthony Akkari
Apr 22, 2017·Journal of Molecular Neuroscience : MN·Sébastien FeuilletteMagalie Lecourtois
Aug 31, 2020·PeerJ·Greta MusteikyteVytautas Smirnovas
Nov 24, 2017·The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutica·Donatienne van WeehaegheKoen van Laere
Nov 30, 2019·Frontiers in Molecular Neuroscience·Cameron WellsNitin K Saksena
Jul 19, 2019·Frontiers in Neuroscience·Audrey M G RagagninJulie D Atkin
Dec 1, 2017·Journal of Neuropathology and Experimental Neurology·Heiko Braak, Kelly Del Tredici
Sep 6, 2020·Cells·Yoshihisa WatanabeMasaki Tanaka
Jan 23, 2021·International Journal of Molecular Sciences·Sophie LayalleLaurent Soustelle
Apr 27, 2021·Frontiers in Aging Neuroscience·Guan-Yong OuWei-Jiang Zhao
Jun 9, 2021·Nature Structural & Molecular Biology·Hannah J Wiedner, Jimena Giudice
Jul 28, 2021·PLoS Computational Biology·Justin TorokAshish Raj
Aug 27, 2021·BMC Medical Genomics·Xue JiangGuan Ning Lin
Apr 28, 2021·Brain : a Journal of Neurology·Eleonora Dalla BellaGiuseppe Lauria

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.